HPC
HM Payson & Co Portfolio holdings
AUM
$5.7B
1-Year Return
8.86%
This Quarter Return
+8.45%
1 Year Return
+8.86%
3 Year Return
+37.55%
5 Year Return
+149.98%
10 Year Return
+262.8%
AUM
$4.45B
AUM Growth
+$284M
(+6.8%)
Cap. Flow
-$13.1M
Cap. Flow
% of AUM
-0.29%
Top 10 Holdings %
Top 10 Hldgs %
34.33%
Holding
1,081
New
59
Increased
179
Reduced
284
Closed
85
Top Buys
| 1 |
Marathon Petroleum
MPC
|
$41.2M |
| 2 |
Adobe
ADBE
|
$27.9M |
| 3 |
Norfolk Southern
NSC
|
$14.8M |
| 4 |
Meta Platforms (Facebook)
META
|
$12.3M |
| 5 |
Otis Worldwide
OTIS
|
$7.11M |
Top Sells
| 1 |
Pfizer
PFE
|
$28.2M |
| 2 |
CVS Health
CVS
|
$23.6M |
| 3 |
Bristol-Myers Squibb
BMY
|
$15.7M |
| 4 |
UnitedHealth
UNH
|
$14.3M |
| 5 |
NVIDIA
NVDA
|
$7.98M |
Sector Composition
| 1 | Technology | 29.47% |
| 2 | Healthcare | 16.06% |
| 3 | Financials | 12.32% |
| 4 | Consumer Discretionary | 10.19% |
| 5 | Industrials | 10.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Booking.com
BKNG
$178B
| $192K | ﹤0.01% |
71
| – | – |
|
377
Broadridge
BR
$29.4B
| $189K | ﹤0.01% |
1,143
| – | – |
|
378
Globe Life
GL
$11.3B
| $187K | ﹤0.01% |
1,709
+696
| +69% | +$76.3K |
|
379
Raymond James Financial
RJF
$33B
| $187K | ﹤0.01% |
1,800
+177
| +11% | +$18.4K |
|
380
CME Group
CME
$94.4B
| $187K | ﹤0.01% |
1,008
-349
| -26% | -$64.7K |
|
381
Equinix
EQIX
$75.7B
| $186K | ﹤0.01% |
237
+87
| +58% | +$68.2K |
|
382
Vanguard Small-Cap Growth ETF
VBK
$20.4B
| $186K | ﹤0.01% |
808
| – | – |
|
383
Highwoods Properties
HIW
$3.44B
| $184K | ﹤0.01% |
7,700
| – | – |
|
384
Eversource Energy
ES
$23.6B
| $184K | ﹤0.01% |
2,595
-725
| -22% | -$51.4K |
|
385
First Trust Large Cap Core AlphaDEX Fund
FEX
$1.36B
| $183K | ﹤0.01% |
2,180
| – | – |
|
386
iShares Russell 2000 Value ETF
IWN
$11.9B
| $183K | ﹤0.01% |
1,299
| – | – |
|
387
Agilent Technologies
A
$36.5B
| $178K | ﹤0.01% |
1,483
| – | – |
|
388
FTI Consulting
FCN
$5.46B
| $178K | ﹤0.01% |
936
| – | – |
|
389
DexCom
DXCM
$31.6B
| $175K | ﹤0.01% |
1,364
+200
| +17% | +$25.7K |
|
390
Brookfield
BN
$99.5B
| $175K | ﹤0.01% |
5,200
| – | – |
|
391
iShares Biotechnology ETF
IBB
$5.8B
| $175K | ﹤0.01% |
1,375
| – | – |
|
392
Penumbra
PEN
$11B
| $172K | ﹤0.01% |
500
| – | – |
|
393
Okta
OKTA
$16.1B
| $172K | ﹤0.01% |
2,478
| – | – |
|
394
Energy Transfer Partners
ET
$59.7B
| $171K | ﹤0.01% |
13,442
| – | – |
|
395
AstraZeneca
AZN
$253B
| $169K | ﹤0.01% |
2,359
+280
| +13% | +$20K |
|
396
Technology Select Sector SPDR Fund
XLK
$84.1B
| $168K | ﹤0.01% |
968
| – | – |
|
397
Estee Lauder
EL
$32.1B
| $168K | ﹤0.01% |
854
-201
| -19% | -$39.5K |
|
398
Cognizant
CTSH
$35.1B
| $166K | ﹤0.01% |
2,550
-297
| -10% | -$19.4K |
|
|
WBA
399
DELISTED
Walgreens Boots Alliance
WBA
| $166K | ﹤0.01% |
5,830
-871
| -13% | -$24.8K |
|
400
Jefferies Financial Group
JEF
$13.1B
| $163K | ﹤0.01% |
4,925
+3,700
| +302% | +$123K |
|